High Willingness to Deprescribe Among People Living with Dementia and Mild Cognitive Impairment
Author(s)
Maiyani M1, Reeve E2, Bayliss E1, Shetterly S1, Gleason K1, Boyd C3
1Kaiser Permanente, Aurora, CO, USA, 2University of south Australia, Adelaide, SA, Australia, 3Johns Hopkins University, Baltimore, MD, USA
Presentation Documents
Objectives: There is limited knowledge about how people living with dementia feel about their medications and possible deprescribing. We used the revised Patients’ Attitude Towards Deprescribing questionnaire for older people living with cognitive impairment (rPATDcog) to capture the beliefs and attitudes about deprescribing among persons living with dementia and cognitive impairment. This study aimed to explore the association between patients’ characteristics and their willingness to deprescribe. Methods: The Optimize study is a pragmatic, cluster-randomized trial educating patients and clinicians about deprescribing. Eligible participants were 65+, diagnosed with dementia, or mild cognitive impairment, and prescribed at least 5 chronic medications. Persons in intervention clinics received the rPATDcog survey prior to a scheduled primary care visit. Results: The survey was mailed to 1,431 patients and 553 (39%) completed surveys were returned. Participants who responded to the survey were older (80.1 vs 79.8) and more likely to be non-hispanic white than non-responders (p<0.05). 56% (310/553) of surveys were known to be answered by patients and 10% by caregivers (55/553). 78% (431/553) of participants were willing to stop one or more of their medications if their doctor said it was possible. 79% of participants were willing to deprescribe and results were similar by age, race, gender, median family income and neighborhood deprivation index (all p>0.05). 75% (413/553) of participants said they were satisfied with their current medications; willingness to deprescribe was slightly lower in this group compared to persons less satisfied with their regimens (76.2% vs 84.9% chi-square p=0.04). Conclusions: A consistently high proportion of patients living with dementia were willing to deprescribe if their doctor said it was possible. These findings can be used to educate clinicians and encourage patients to discuss deprescribing with their clinicians which may lead to an increase in deprescribing discussions.
Conference/Value in Health Info
2022-05, ISPOR 2022, Washington, DC, USA
Value in Health, Volume 25, Issue 6, S1 (June 2022)
Code
HSD18
Topic
Patient-Centered Research, Study Approaches
Topic Subcategory
Stated Preference & Patient Satisfaction
Disease
Neurological Disorders